The Role of Octreotide in the Preoperative and Perioperative Management of a Neuroendocrine Tumor

Authors

Vivian Chang, Oakland University William Beaumont School of Medicine Medical Student
Paragi Patel, Beaumont Health Resident
Roy G. Soto, Beaumont Health

Document Type

Conference Proceeding

Publication Date

10-15-2023

Abstract

Our patient is a 68-year-old female with a medical history of congestive heart failure, atrial fibrillation, and sick sinus syndrome with a pacemaker who presented with loose bowel movements, emesis, and significant weight loss. Further work-up revealed a neuroendocrine tumor of the distal ileum with metastasis to the liver. She began receiving monthly octreotide injections and presented for resection of the terminal ileum, right colon, and mesenteric lymph nodes. In this case presentation, we will discuss the mechanism of action of octreotide and its role in both the preoperative and perioperative management of patients with neuroendocrine tumors.

Comments

American Society of Anesthesiologists Annual Meeting, October 12-16, 2023, San Francisco, CA

Recommended Citation

Chang V, Patel P, Soto RG. The role of octreotide in the preoperative and perioperative management of a neuroendocrine tumor. Presented at: American Society of Anesthesiologists Annual Meeting; 2023 Oct 15; San Francisco, CA.